Related Experiment Video
Updated: Sep 21, 2025

06:19
Comparison of Three Clinical Stereoscopic Methods for Measuring Binocular Visual Function During Amblyopic Treatment in Unilateral Amblyopia
Published on: September 27, 2024
306
Comparison of Two Different Contrast Sensitivity Testing Methods in Patients with Low Vision
Deniz Altinbay1,2,3, Esra Sahli2,3, Aysun Idil2
1Özel Niv Eye Center, Adana, Turkey.
Journal of Current Ophthalmology
|May 27, 2022
Summary
This study compared two contrast sensitivity tests for low vision patients. While an agreement was found, the wide limits suggest the tests may not be interchangeable in clinical practice.
Area of Science:
- Ophthalmology
- Vision Science
- Low Vision Research
Background:
- Contrast sensitivity (CS) is crucial for visual function.
- Assessing CS in low vision patients requires reliable testing modalities.
- Evaluating agreement between different CS tests is essential for clinical application.
Purpose of the Study:
- To assess the agreement between the Vector vision-standardized CS test (CSV-1000E) and the MonPack 3 test using the index of contrast sensitivity (ICS).
- To determine if these two contrast testing modalities are interchangeable in clinical practice for patients with low vision.
Main Methods:
- Thirty-eight low vision patients participated.
- Contrast sensitivity was measured binocularly using CSV-1000E and MonPack 3 after refractive correction.
- The Index of Contrast Sensitivity (ICS) was calculated, and agreement was evaluated using the Bland-Altman technique.
Main Results:
- CS values peaked at 3 cycles per degree (cpd) for CSV-1000E and 1.5 cpd for MonPack 3.
- Median ICS values were -0.22 for CSV-1000E and 0.08 for MonPack 3.
- The Bland-Altman analysis showed agreement within wide limits of agreement (LoA), with a mean difference of 0.655.
Conclusions:
- An agreement exists between the Metrovision MonPack 3 and CSV-1000E tests in low vision patients.
- However, the wide limits of agreement indicate that these tests may not be interchangeable in clinical settings.
- Further research may be needed to refine CS testing for low vision populations.

